Fortress Biotech, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $17.2M | $16.5M | $863.0K | $0 | $0 |
| Cost of Revenue | $3.7M | $790.0K | $0 | — | — |
| Gross Profit | $13.6M | $15.7M | $863.0K | — | — |
| Gross Margin | 78.8% | 95.2% | 100.0% | — | — |
| Operating Expenses | |||||
| Research & Development | $48.3M | $35.1M | $29.8M | $10.2M | $25.7M |
| SG&A Expense | $50.9M | $28.2M | $18.7M | $10.4M | $10.1M |
| Operating Income | $-89.8M | $-65.7M | $-50.5M | $-20.7M | $-35.8M |
| Operating Margin | -520.7% | -398.7% | -5,855.3% | — | — |
| Interest Expense | $5.9M | $3.7M | $1.5M | $1.3M | $1.9M |
| Pretax Income | $-97.5M | $-71.3M | $-53.9M | — | — |
| Income Tax Expense | $1.5M | $0 | $0 | — | — |
| Net Income | $-66.9M | $-55.1M | $-48.4M | $-20.4M | $-37.2M |
| Net Margin | -387.8% | -334.3% | -5,611.6% | — | — |
| EPS (Basic) | $-0.54 | $-0.46 | $-0.41 | $-0.19 | $-0.41 |
| EPS (Diluted) | $-0.54 | $-0.46 | $-0.41 | $-0.19 | $-0.41 |
| Shares Outstanding (Basic) | 153.0M | 146.8M | 141.4M | 139.5M | 119.0M |
| Shares Outstanding (Diluted) | 153.0M | 146.8M | 141.4M | 139.5M | 119.0M |
| Dividends Per Share | — | — | — | — | — |